Authoritative release of 2017 China Pharmaceutical R & D strength ranking
-
Last Update: 2017-09-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
From September 8 to 10, 2017, under the guidance of China Pharmaceutical University, Chongqing Economic and Information Technology Commission, China Pharmaceutical Education Association, the second "2017 China Pharmaceutical Summit Forum and top 100 research and development strength list of pharmaceutical enterprises" hosted by pharmaceutical intelligence network and China Pharmacy magazine was held in Wanda Aimei Hotel, Chongqing More than 500 experts and celebrities from more than 20 provinces and cities gathered to discuss the future pattern of China's pharmaceutical R & D and innovation, and gather the top wisdom of China's pharmaceutical industry to promote the in-depth development of the industry At this conference, the Chinese medicine research and development strength list, chemical medicine list, biological medicine list, brand list and general list of 2017, which attracted the attention of the industry, were announced, causing a sensation in the industry The ranking list of pharmaceutical intelligence network has been updated in real time according to the announcement of the list You are welcome to move to the ranking list of 2017 China's pharmaceutical R & D strength Enter the leaderboard The 2017 China Pharmaceutical R & D strength ranking is composed of the 2017 China Pharmaceutical R & D comprehensive strength ranking (hereinafter referred to as the "general list") and the 2017 China chemical R & D strength ranking (hereinafter referred to as the "chemical list"), 2017 China traditional Chinese medicine R & D strength ranking (hereinafter referred to as the "traditional Chinese medicine list"), 2017 China biological drug R & D strength ranking (hereinafter referred to as the "biological drug list") ”), 2017 China Pharmaceutical R & D brand ranking (hereinafter referred to as "brand list") is composed of four sub lists The statistical contents include: score of drug acceptance and approval in 2016, score of R & D investment of pharmaceutical enterprises in 2016, score of ranking list in 2016 and score of brand list (voting score) View scoring rules
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.